The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a ventral incisional hernia.
It was reported that after the implant, the patient experienced post operative incisional seroma, infected mesh, abscess, pain, lack of incorporation, scar, chronic inflammation (including plasma cells, lymphocytes, histocytes, multinucleated giant cells, eosinophils, rare neutrophils), non-healing wound, fibrosis, foreign body reaction, foreign body granuloma, draining sinus tract, and attenuated fascia.
Post-operative patient treatment included wound debridement, incision and drainage, debridement down to fascial tissue, excision of infected hernia mesh, panniculectomy, removal of intraperitoneal and extraperitoneal infected hernia mesh, and repair of incisional hernia with phasix biologic mesh.
|